<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">26451116</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>10</Month>
            <Day>09</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1178-6930</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2015</Year>
                    </PubDate>
                </JournalIssue>
                <Title>OncoTargets and therapy</Title>
                <ISOAbbreviation>Onco Targets Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2571-6</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2147/OTT.S81915</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lung cancer poses a severe threat to human life. Biomarkers of cancers are helpful in the diagnosis and treatment of patients with cancers. Biomarkers of lung cancers are rare, and thus deserve further research.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of the present study was to explore the expression of Fascin-1 in human lung cancer and paracarcinoma tissue, its correlation with clinicopathological characteristics in patients with lung cancer, and study the possible relationship between Fascin-1 expression and clinical-biological behavior of lung cancer.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">This study used the MaxVision two-step immunohistochemical detection method to detect Fascin-1 expression in 84 of lung cancer and paracarcinoma tissues. This study set the expression of Fascin-1 in vascular endothelial cells as the positive control, and used phosphate buffered saline (replacing the primary antibodies) as negative control.</AbstractText>
                <AbstractText Label="RESULT" NlmCategory="RESULTS">Of all the 84 lung cancer tissues and paracarcinoma tissues, positive expression of the Fascin-1 protein were detected in 78 cases (92.9%) and 27 cases (32.1%), respectively, and the difference was statistically significant (P&lt;0.05). Differences in Fascin-1 expression between different age groups, clinical stages, and lymph node metastases were statistically significant (P&lt;0.05), while differences in Fascin-1 expression between sexes, tumor stages, and pathological types demonstrated no statistical significance (P&gt;0.05). The survival times of the patients with different Fascin-1 protein-positive expressions in lung cancer tissues were statistically significant (P&gt;0.05), while the survival times of the patients with different Fascin-1 protein-positive expressions in paracarcinoma tissues were not statistically significant (P&gt;0.05).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In lung cancer, Fascin-1 expression was closely related to tumor invasion and metastasis, and the difference in expression of Fascin-1 had a significant effect on the survival time of the lung cancer patients. Therefore, Fascin-1 might be expected to serve as a possible potential biomarker of lung cancer.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Third Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Third Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Third Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Qiu-Hong</ForeName>
                    <Initials>QH</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Third Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zhi-Gang</ForeName>
                    <Initials>ZG</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Third Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Hui-Ling</ForeName>
                    <Initials>HL</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Third Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xing</LastName>
                    <ForeName>Li-Hua</ForeName>
                    <Initials>LH</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Third Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2015</Year>
                <Month>09</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Onco Targets Ther</MedlineTA>
            <NlmUniqueID>101514322</NlmUniqueID>
            <ISSNLinking>1178-6930</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Fascin-1 protein</Keyword>
            <Keyword MajorTopicYN="N">immunohistochemistry</Keyword>
            <Keyword MajorTopicYN="N">pulmonary carcinoma</Keyword>
            <Keyword MajorTopicYN="N">survival time</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2015</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2015</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>10</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">26451116</ArticleId>
            <ArticleId IdType="doi">10.2147/OTT.S81915</ArticleId>
            <ArticleId IdType="pii">ott-8-2571</ArticleId>
            <ArticleId IdType="pmc">PMC4592059</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 2014 Oct 14;111(8):1552-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25117814</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Melanoma Res. 2015 Apr;25(2):169-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25535872</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2000 Oct;6(10):4064-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11051257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung Cancer. 2003 Nov;42(2):203-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14568688</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Mol Diagn. 2015 Jan;15(1):41-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25370828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Surg Res. 2012 Jan;172(1):102-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20851411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Signal. 2006 Mar;18(3):276-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16109477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2010 Mar;21(3):589-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19759191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Cardiovasc Med. 2004 Aug;14(6):221-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15451513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cell Biol. 2014 Oct;93(10-12):388-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25269996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2005 Jan 1;11(1):186-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15671545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2003 Feb 24;88(4):537-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12592367</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Histochem Cytochem. 2008 Feb;56(2):193-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17998567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2010 Apr 28;290(2):238-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19819618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2014 Oct 24;289(43):30082-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25213863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2004 Dec 15;10(24):8465-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15623626</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>